Boston Professional Events List


CANCER ADVANCE BOSTON - APRIL 11, 2017 - DRAFT


Date
Apr 11, 2017 - 11:00 AM - 06:30 PM
Organizer
Boston Biotech
Location
Harvard Medical School - Joseph B. Martin Conference Center77 Avenue Louis PasteurBoston, MA 02115,

Boston,
MA ,
US,
ZIP: 02115
Phone:

Ticket Price: $1950
Cancer Advance

CONFERENCE DETAILS

Join some of the most distinguished cancer experts from academia and industry, alongside the people who help turn discoveries into therapies—biotech entrepreneurs, venture capitalists, buysiders, bankers and analysts—for a high-energy, uniquely interactive meeting at Harvard Medical School where networking and discussion take center stage. 



Agenda


CANCER ADVANCE BOSTON - APRIL 11, 2017 - DRAFT
Co-hosts: Rafael Amado, Robert Bazemore, Pablo Cagnoni, James Cappuccio, George Demetri, Luc Dochez, Giulio Draetta, Edward Garmey, Chris Guiffre, Bill Hicks, Colin Hill, Reid Huber, Michael Kauffman, Joe Leveque, David Meek, Walter Ogier, Louise Perkins, Ferran Prat, Daniel Teper, Robert Urban, Markus Warmuth, Steve Worland
Time Agenda
11:00-12:00 pm Registration and Networking Lunch
12:00-12:20 pm Welcoming Remarks
John Burke, Applied BioMath; Jeff Smith, H.C. Wainwright & Co.; Andrew Schiermeier, EMD Serono; Markus Warmuth, H3 Biomedicine
12:20-1:00 pm Oncology 2016: Trends to Watch
Edward Garmey, Bicycle Therapeutics; Jim Healy, Sofinnova Ventures; Jodie Morrison, Tokai Pharmaceuticals; Niven Narain, Berg; Markus Warmuth, H3 Biomedicine
Moderator: Jennifer Wheler, Novartis
1:00-1:40 pm Novel Therapeutic Modalities
Sudhir Agrawal, Idera Pharmaceuticals; Peter Blume-Jensen, XTuit; Giulio Draetta, MD Anderson Cancer Center; Adi Hoess, Affimed Therapeutics; Mark Velleca, G1 Therapeutics
Moderator: John Burke, Applied BioMath
1:40-2:20 pm Focus on Immunotherapy: New Indications and Targets
Björn Frendéus, BioInvent; Mike King, JMP Securities; Jonathan Pachter, Verastem; Ifat Rubin-Bejerano, ImmuneXcite;Kristine Swiderek, Theraclone Sciences
Moderator: Rafael Amado, Adaptimmune
2:20-3:00 pm Biomarkers and Novel Clinical Designs for Patient Stratification
David Mack, PMV Pharma; Will McCarthy, Ignyta; Chad Robins, Adaptive Biotechnologies; Roger Sidhu, Amgen
Moderator: Belen Carrillo-Rivas, Pfizer
3:00-3:40 pm Networking Break
3:40-4:10 pm Fireside Chat
Liz Barrett, Global President and General Manager of Oncology, Pfizer; Andrew Schiermeier, SVP and Global Head of Oncology, EMD Serono
Moderator: Paul Lammers, President and CEO, Mirna Therapeutics
4:10-4:50 pm Combination Therapy
Jeffrey Bacha, DelMar Pharmaceuticals; Steven Fruchtman, Onconova Therapeutics; Reid Huber, Incyte; Michael Kauffman, Karyopharm Therapeutics; Walter Ogier, Acetylon Pharmaceuticals
Moderator: Robert Stein, Agenus
4:50-5:30 pm Oncology Deals and Partnerships: Balancing Risk
Anne Altmeyer, Baxalta; Michael Attar, Celgene; Mitch Gold, Alpine Immune Sciences; Robert Radinsky, Janssen Research & Development; Jeffrey Wiesen, Mintz Levin
Moderator: Robert Forrester, Verastem
5:30-6:30 pm Networking Cocktails and Hors d'oeuvres
CANCER ADVANCE BOSTON - APRIL 11, 2017 - DRAFT
Co-hosts: Rafael Amado, Robert Bazemore, Pablo Cagnoni, James Cappuccio, George Demetri, Luc Dochez, Giulio Draetta, Edward Garmey, Chris Guiffre, Bill Hicks, Colin Hill, Reid Huber, Michael Kauffman, Joe Leveque, David Meek, Walter Ogier, Louise Perkins, Ferran Prat, Daniel Teper, Robert Urban, Markus Warmuth, Steve Worland
Time Agenda
7:00-8:00 am Registration and Networking Breakfast
8:00-8:40 am Industry Collaborations with Academia and Foundations
Anne Deconinck, MIT Koch Institute; Lee Greenberger, The Leukemia & Lymphoma Society; Iya Khalil, GNS Healthcare; Joe Leveque, EMD Serono; Jonathan Lewis, Samus Therapeutics 
Moderator: Louise Perkins, Melanoma Research Alliance
8:40-9:10 am Bench to Bedside Keynote: The Story Behind the Story: Keytruda’s Breakthrough Designation and Beyond
Joseph Eid, VP and Head of Oncology Global Medical Affairs, Merck 
Moderator: Giulio Draetta, Director of the Institute for Applied Cancer Science, MD Anderson Cancer Center
9:10-9:50 am Investor Perspectives on the Oncology Market
James Cappuccio, H.C. Wainwright & Co. Carolyn Green, Pfizer; Thilo Schroeder, Nextech Invest; Sofie Qiao, Vivace Therapeutics
Moderator: Mark Simon, Torreya Partners
9:50-10:30 am Checkpoint Inhibitors: What’s New?
Harry Gruber, Tocagen; Christian Rohlff, Oxford BioTherapeutics; Daniel Teper, Immune Pharmaceuticals; Kevin Webster, eFFECTOR Therapeutics
Moderator: Joanna Horobin, Idera Pharma
10:30-11:00 am Innovative Deal Structures in Oncology
Detlev Biniszkiewicz, Surface Oncology; John DeYoung, Pfizer; David Donabedian, Longwood Fund; John Haurum, F-star Biotechnology; Geeta Vemuri, Baxalta Ventures
Moderator: Robert Urban, Johnson & Johnson Innovation
11:00-11:30 am Connecting With Patients
Manuel Aivado, Aileron Therapeutics; Mark Erlander, Trovagene; Matthew Kim, Vigilant Biosciences; Philina Lee, Blueprint Medicines 
Moderator: Jennifer Levin Carter, N-of-One
11:30-12:30 pm Networking Lunch 
12:30-1:00 pm Fireside Chat: Precision Oncology
Jay Flatley, President and CEO, Illumina
Moderator: Robert Bazemore, President and CEO, Epizyme
1:00-1:30 pm Oncology Drugs: Defining Value
Richard Popiel, Regence BlueCross BlueShield; Peter Smith, H3 Biomedicine; Patrick Tricoli, Nanobiotix; Sam Waksal, Kadmon
Moderator: Colin Hill, GNS Healthcare
1:30-2:00 pm T Cell Therapies: What’s New?
David Chang, Kite Pharma; Eric Hoffman, Genocea Biosciences; Dolores Schendel, Medigene; Beth Trehu, Jounce Therapeutics
Moderator: Biren Amin, Jefferies
2:00-2:40 pm Immunotherapy Discussion
Errik Anderson, Compass Therapeutics; Steve Arkinstall, Kymab; Chris Boshoff, Pfizer; Pablo Cagnoni, Tizona Therapeutics
Moderator: Ferran Prat, MD Anderson Cancer Center
2:40-3:20 pm Networking Break
3:20-4:00 pm Big Pharma vs Biotech in the Oncology Space
Anna Berkenblit, ImmunoGen; Ryan Cohlhepp, Takeda; Oliver Rosen, Deciphera Pharmaceuticals; Ben Thorner, Merck 
Moderator: David Meek, Baxalta
4:00-4:40 pm Reimbursement: 2016 Trends and Future Outlook
Atul Dhir, New Century Health; Ronaldo Fujii, EMD Serono; Michael Kolodziej, Aetna; Bill McGivney, McGivney Global Advisors
Moderator: Jim Coccia, Takeda
4:40-5:20 pm The Next 10 Years: Predictions and Wishes
John Herrmann, Catenion; John Hohneker, FORMA Therapeutics; Richard Lanman, Guardant Health; Josh Resnick, SV Life Sciences; Birgit Schoeberl, Merrimack Pharma 
Moderator: Tim Clackson, ARIAD Pharmaceuticals
5:20-6:30 pm Closing Remarks
George Demetri, Director of The Center for Sarcoma and Bone Oncology, Dana Farber Cancer Institute
Presentation of the Oncology Innovation of the Year Award
Networking Cocktails and Hors d'oeuvres
 

Event Categories
Keywords: conference , industry , network , networking , bank , capital, conference , Conference , energy, Entrepreneur




Comments








Events Calendar

SunMonTueWedThuFriSat
26 27 28 29 30 31 1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 1 2 3 4 5 6

Tag Cloud

Event Location

Newsletters

Subscribe
VIP Life Time Subscription to our Newsletters!
$399.99
$299.99